selective mc4r antagonists (Santhera Pharmaceuticals)
Structured Review
Selective Mc4r Antagonists, supplied by Santhera Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selective+mc4r+antagonists/mc+4r+antagonist+program+bl+6020+979/pm20367196-25-19-2
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference. Article Snippet: Cachexia is an illness that may occur in terminal stages of many chronic illnesses including cancer, chronic heart failure, chronic renal failure or chronic obstructive pulmonary disease.. Effective treatments are urgently needed in order to improve the patients’ quality of life and their survival.. We report highlights from the 5th Cachexia Conference held in December 2009 in Barcelona, Spain. |

